43
$10M
102$10M$50M
94$10M
160$10M$50M
25
537$50M$100M
64$10M
64$10M
112$10MSagimet Biosciences uses 8 technology products and services including SAS, Microsoft Word, Amazon ALB, and more. Explore Sagimet Biosciences's tech stack below.
| Sagimet Biosciences Email Formats | Percentage |
| First.Last@3vbio.com | 71% |
| FLast@3vbio.com | 17% |
| Last@3vbio.com | 12% |
| First.Last@sagimet.com | 88% |
| Last@sagimet.com | 6% |
| First.Last@sagimet.com | 6% |
Pharmaceutical ManufacturingCalifornia, United States11-50 Employees
Sagimet Biosciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat important diseases such as the liver disease NASH and specific cancers, with focus on targeting dysfunctional metabolic pathways. The company has unique expertise in FASN biology and has created a platform of proprietary FASN inhibitors. For more information, please visit www.sagimet.com.
Company Overview
Media & News
Funding & FinancialsSagimet Biosciences has raised a total of $113M of funding over 13 rounds. Their latest funding round was raised on Jan 25, 2024 in the amount of $113M.
Sagimet Biosciences's revenue is in the range of $10M
Funding & FinancialsSagimet Biosciences has raised a total of $113M of funding over 13 rounds. Their latest funding round was raised on Jan 25, 2024 in the amount of $113M.
Sagimet Biosciences's revenue is in the range of $10M
1-888-653-2347 
support@leadiq.com